Trademark Search  /  MONUDIN

MONUDIN

○ Dead · Cancelled

U.S. federal trademark · Serial No. 85693119 · Reg. No. 3110731

Mark
MONUDIN
Status
Cancelled
Serial Number
85693119
Registration No.
3110731
Filing Date
August 1, 2012
Registration Date
January 14, 2005
Class(es)
Class 001, Class 005, Class 010, Class 042

Owners

Oxford BioMedica plc
99 · Oxford OX4 6LT, GB
Oxford BioMedica plc
99 · Oxford, GB
Oxford BioMedica plc
99 · Oxford, GB

Goods & Services

Instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, empty vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization

Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology

Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy

Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "MONUDIN" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.